Command Palette

Search for a command to run...

dr-lalchandani-labs

21.58+0.00%
Market Cap
₹0.00 Cr
Stock P/E
0.00
ROCE
0.00%
ROE
0.00%
Book Value
₹0.00

You might have missed

No Recent News

No recent news available for this stock.

Shareholding

Holdings
Distribution
Promoter
Public
Others

From Last Concall

No Concall Summary

Conference call summary is not available for this stock.

Peers Summary

Sector Leader

Dr Lalchandani Labs Ltd. shows significant underperformance compared to its peers, with no growth metrics or profitability indicators. The sector is led by companies like Max Healthcare and Apollo Hospitals with strong growth, profitability, and efficient operations. Companies like Aster DM Healthcare represent deep value but show concerning financial performance, while others like Fortis Healthcare appear financially risky due to high valuation metrics and low profitability.

Key Points
  • Dr Lalchandani Labs has no revenue or EPS growth, ROE, ROA, or ROCE compared to peers.
  • Max Healthcare leads in revenue growth and profitability, while Aster DM Healthcare is a low PE value pick with high risk.
  • Most companies show strong growth except for Dr Lalchandani Labs and Fortis Healthcare.
Top Performers
Max Healthcare Institute Ltd.

Highest revenue growth (YoY 18.49%) and strong profitability metrics (ROE 13.47%).

Apollo Hospitals Enterprise Ltd.

Strong revenue growth (YoY 14.73%) and high ROE (20.51%).

Narayana Hrudayalaya Ltd.

Solid growth (YoY 10.91%) and high ROE (24.27%).

Leveling the playing field in markets.

© 2025 EQHQ Technologies Pvt Ltd

"Information provided is for educational purposes only and not financial advice.